Search results
Left in limbo: When pharma halts rare disease research
Pharmaceutical Technology· 6 days agoThe overall survival with the gene therapy was 100% in all studies up to 36 months. Event-free...
EAN 2024: Treatment cessation and reinitiation can reduce benefits of Ajovy
Clinical Trials Arena· 7 days agoFurther, the PEARL study also showed that...Federation (EHF) guidelines, published in 2022, state...